Abstract
THE use of β-glucuronidase as an agent for the liberation of a steroid from its urinary glucurpnide conjugate has now become standard practice. The overall rate of the enzyme action is unpredictable, however, due to the presence in the urine of natural inhibitors and other substrates of varying affinity and ease of hydrolysis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marsh, C. A., Biochem. J., 79, 21P (1961).
Marsh, C. A. (unpublished observations).
Levvy, G. A., Biochem. J., 52, 464 (1952).
Stempfel, R. S., Sidbury, J. B., and Migeon, C. J., J. Clin. Endocrinol. and Metabolism, 20, 814 (1960).
Levvy, G. A., and Marsh, C. A., Adv. Carbohydrate Chem., 14, 381 (1959).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MARSH, C. Inhibition of β-Glucuronidase by Endogenous Saccharate during Hydrolysis of Urinary Conjugates. Nature 194, 974–975 (1962). https://doi.org/10.1038/194974a0
Issue Date:
DOI: https://doi.org/10.1038/194974a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
